Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model
Conclusions: Human fetal stem cells are valuable source for cell therapy and co-transplantation of mesenchymal stromal cells can improve therapeutic effects of hematopoietic stem cells.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Type 1 | Endocrinology | Legislation | Liver | Liver Transplant | Pancreas | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology